Regulatory approval and market access: a winning combination for drug launch optimization
This article was originally published in SRA
Marcus Deans, Mark A De Rosch and Emmanuelle Voisin emphasize that having a combined regulatory and market access strategy is critical for a drug launch to be successful.
You may also be interested in...
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.